Press Release of U.S. Senator Barbara Boxer

For Immediate Release:
February 8, 2005  
Washington D.C. Office (202) 224-3553

Senator Boxer Supports Alzheimer’s Research  

For many, Alzheimer’s Disease is both mysterious and frightening.  It seems to strike without warning, causing memory and many cognitive functions to dwindle and fade. 

Our understanding of Alzheimer’s is still unfolding, with effective treatments and a cure still in the development stages.  However, there is good news that a diagnostic procedure may be developed that may help us to better identify Alzheimer’s cases earlier, when treatment could be the most effective.

Early tests of this new diagnostic procedure shows that it may be possible to detect a chemical marker associated with Alzheimer’s in the spinal fluid.  This chemical marker is amyloid-beta-derived diffusible ligand, or ADDL.  Though this early finding, sponsored in part by the National Science Foundation, shows promise for our understanding of Alzheimer’s Disease, additional work will be needed before we know if this is a breakthrough we need to identify early cases of Alzheimer’s.

In the last Congress, I was pleased to cosponsor the Ronald Reagan Alzheimer's Breakthrough Act of 2004, authored by Senator Barbara Mikulski (D-MD).  This legislation would have remarkably increased funding for research into Alzheimer’s Disease.  You can count on me to again support legislation that will lead to better diagnostic procedures, treatment, and a cure. 

I look forward to hearing from you if you have questions regarding this or any other matter.